BITC for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

BITC for Health & Longevity

Created on 06/13/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

BITC is a sharp-tasting compound from watercress, garden cress, and mustard that switches on detoxification defenses and pushes damaged cells toward self-destruction. Population data tie these vegetable compounds to lower cancer rates, but the purified compound is untested in people. It is biologically promising but clinically unproven, with risks tied mainly to concentrated forms. (Full Review)

Protocol

Dietary delivery
Raw cruciferous greens
Watercress is the richest source; garden cress and mustard greens also contribute. Several servings per week.
Preserve active compound
Chop, rest, eat raw
Myrosinase is heat-sensitive; chop and let stand, eat raw, or add raw mustard seed powder to cooked greens.
Dosing frequency
Regular, distributed
Short half-life favors most-days intake over infrequent large amounts; consume with meals to buffer irritation.
Time to effect
Cancer-risk benefit
Years
Long-horizon, population-level outcome; not perceptible to an individual.
Detox-enzyme induction
Hours to days
Transient; reverses as the compound clears.

Benefits

Contraindications
  • Pregnancy and breastfeeding (concentrated BITC)
  • Active peptic ulcers or significant gastrointestinal inflammation (concentrated BITC)
  • Hypothyroidism or iodine deficiency (concentrated BITC)
  • Significant liver or kidney impairment (concentrated BITC)
    •
Key Interactions
  • Cytochrome P450 substrate medications (some statins, certain benzodiazepines, acetaminophen)
  • Thyroid medications
  • Acetaminophen (paracetamol)
  • Thiol supplements (N-acetylcysteine, glutathione)
  • Other isothiocyanates (sulforaphane, phenethyl isothiocyanate)
    •

Risk & Side Effects

  • High: [risks_high]
    •
  • Medium: Gastrointestinal irritation
    •
  • Low: Pro-oxidant and cytotoxic effects at high doses; thyroid interference
    •
  • Speculative: Drug-metabolism interactions; reproductive and developmental uncertainty
    •

Monitoring

Marker Target Why
TSH 0.5–2.0 mIU/L Screens for goitrogenic impact of high cruciferous intake
hs-CRP < 1.0 mg/L Tracks the anti-inflammatory signal BITC may contribute to
GGT < 20 U/L (lower is better) Reflects glutathione turnover and oxidative/detox load
Comprehensive metabolic panel (liver and kidney function) Within standard reference ranges Surveillance for the theoretical high-dose hepatic/renal effects if using concentrated forms

Cadence: Baseline before increasing intake; re-check at ~3 months after a sustained change, then every 6–12 months.

Qualitative Assessment

  • Digestive comfort (absence of burning, nausea, or stomach upset after BITC-rich meals)
  • Energy levels and general well-being over weeks
  • Any throat or mouth irritation signaling excessive concentrated intake
  • Tolerance to increasing serving sizes
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.